Key result
Acute Trypanosoma cruzi infection alters myocardial gene and microRNA expression, predominantly driven by IFNγ.
Why the study?
The acute phase of Trypanosoma cruzi infection causes myocarditis and profound myocardial gene expression changes, but the role of miRNAs in these pathobiological processes is not well understood.
Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America. Its acute phase is associated with high parasitism, myocarditis and profound myocardial gene expression changes. A chronic phase ensues where 30% develop severe heart lesions. Mouse models of T. cruzi infection have been used to study heart damage in Chagas disease. The aim of this study was to provide an interactome between miRNAs and their targetome in Chagas heart disease by integrating gene and microRNA expression profiling data from hearts of T. cruzi infected mice. Gene expression profiling revealed enrichment in biological processes and pathways associated with immune response and metabolism. Pathways, functional and upstream regulator analysis of the intersections between predicted targets of differentially expressed microRNAs and differentially expressed mRNAs revealed enrichment in biological processes and pathways such as IFNγ, TNFα, NF-kB signaling signatures, CTL-mediated apoptosis, mitochondrial dysfunction, and Nrf2-modulated antioxidative responses. We also observed enrichment in other key heart disease-related processes like myocarditis, fibrosis, hypertrophy and arrhythmia. Our correlation study suggests that miRNAs may be implicated in the pathophysiological processes taking place the hearts of acutely T. cruzi-infected mice.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2017) studied Acute Trypanosoma cruzi infection (Chagas heart disease) (n=36). Trypanosoma cruzi infection vs. Uninfected control mice was evaluated on Differentially expressed genes (DEGs) and miRNAs in heart tissue. Acute Trypanosoma cruzi infection in mice significantly altered myocardial gene and microRNA expression, revealing enrichment in immune, metabolic, and mitochondrial pathways primarily modulated by IFNγ.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: